Polybrominated diphenyl ethers in relation to autism and developmental delay

A case-control study

Irva Hertz-Picciotto, Åke Bergman, Britta Fängström, Melissa Rose, Paula Krakowiak, Isaac N Pessah, Robin L Hansen, Deborah H Bennett

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background. Polybrominated diphenyl ethers (PBDEs) are flame retardants used widely and in increasing amounts in the U.S. over the last few decades. PBDEs and their metabolites cross the placenta and studies in rodents demonstrate neurodevelopmental toxicity from prenatal exposures. PBDE exposures occur both via breastfeeding and hand-to-mouth activities in small children. Methods: Participants were 100 children from the CHARGE (CHildhood Autism Risk from Genetics and the Environment) Study, a case-control epidemiologic investigation of children with autism/autism spectrum disorder, with developmental delay and from the general population. Diagnoses of autism were confirmed by the Autism Diagnostic Observation Schedule and Autism Diagnostic Inventory-Revised, and of developmental delay using the Mullen's Scales of Early Learning and the Vineland Adaptive Behavior Scales. Typically developing controls were those with no evidence of delay, autism, or autism spectrum disorder. Eleven PBDE congeners were measured by gas chromatography/mass spectrometry from serum specimens collected after children were assessed. Logistic regression was used to evaluate the association between plasma PBDEs and autism. Results: Children with autism/autism spectrum disorder and developmental delay were similar to typically developing controls for all PBDE congeners, but levels were high for all three groups. Conclusions: Plasma samples collected post-diagnosis in this study may not represent early life exposures due to changes in diet and introduction of new household products containing PBDEs. Studies with direct measurements of prenatal or infant exposures are needed to assess the possible causal role for these compounds in autism spectrum disorders.

Original languageEnglish (US)
Article number1
JournalEnvironmental Health: A Global Access Science Source
Volume10
Issue number1
DOIs
StatePublished - 2011

Fingerprint

Halogenated Diphenyl Ethers
Autistic Disorder
Case-Control Studies
Household Products
Flame Retardants
Psychological Adaptation
Breast Feeding
Gas Chromatography-Mass Spectrometry
Placenta
Mouth
Rodentia
Appointments and Schedules
Hand
Logistic Models
Observation
Learning
Diet
Equipment and Supplies
Autism Spectrum Disorder

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Public Health, Environmental and Occupational Health
  • Medicine(all)

Cite this

Polybrominated diphenyl ethers in relation to autism and developmental delay : A case-control study. / Hertz-Picciotto, Irva; Bergman, Åke; Fängström, Britta; Rose, Melissa; Krakowiak, Paula; Pessah, Isaac N; Hansen, Robin L; Bennett, Deborah H.

In: Environmental Health: A Global Access Science Source, Vol. 10, No. 1, 1, 2011.

Research output: Contribution to journalArticle

@article{43e3d04073b345e5ae3b24bd1616fbd4,
title = "Polybrominated diphenyl ethers in relation to autism and developmental delay: A case-control study",
abstract = "Background. Polybrominated diphenyl ethers (PBDEs) are flame retardants used widely and in increasing amounts in the U.S. over the last few decades. PBDEs and their metabolites cross the placenta and studies in rodents demonstrate neurodevelopmental toxicity from prenatal exposures. PBDE exposures occur both via breastfeeding and hand-to-mouth activities in small children. Methods: Participants were 100 children from the CHARGE (CHildhood Autism Risk from Genetics and the Environment) Study, a case-control epidemiologic investigation of children with autism/autism spectrum disorder, with developmental delay and from the general population. Diagnoses of autism were confirmed by the Autism Diagnostic Observation Schedule and Autism Diagnostic Inventory-Revised, and of developmental delay using the Mullen's Scales of Early Learning and the Vineland Adaptive Behavior Scales. Typically developing controls were those with no evidence of delay, autism, or autism spectrum disorder. Eleven PBDE congeners were measured by gas chromatography/mass spectrometry from serum specimens collected after children were assessed. Logistic regression was used to evaluate the association between plasma PBDEs and autism. Results: Children with autism/autism spectrum disorder and developmental delay were similar to typically developing controls for all PBDE congeners, but levels were high for all three groups. Conclusions: Plasma samples collected post-diagnosis in this study may not represent early life exposures due to changes in diet and introduction of new household products containing PBDEs. Studies with direct measurements of prenatal or infant exposures are needed to assess the possible causal role for these compounds in autism spectrum disorders.",
author = "Irva Hertz-Picciotto and {\AA}ke Bergman and Britta F{\"a}ngstr{\"o}m and Melissa Rose and Paula Krakowiak and Pessah, {Isaac N} and Hansen, {Robin L} and Bennett, {Deborah H}",
year = "2011",
doi = "10.1186/1476-069X-10-1",
language = "English (US)",
volume = "10",
journal = "Environmental Health: A Global Access Science Source",
issn = "1476-069X",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Polybrominated diphenyl ethers in relation to autism and developmental delay

T2 - A case-control study

AU - Hertz-Picciotto, Irva

AU - Bergman, Åke

AU - Fängström, Britta

AU - Rose, Melissa

AU - Krakowiak, Paula

AU - Pessah, Isaac N

AU - Hansen, Robin L

AU - Bennett, Deborah H

PY - 2011

Y1 - 2011

N2 - Background. Polybrominated diphenyl ethers (PBDEs) are flame retardants used widely and in increasing amounts in the U.S. over the last few decades. PBDEs and their metabolites cross the placenta and studies in rodents demonstrate neurodevelopmental toxicity from prenatal exposures. PBDE exposures occur both via breastfeeding and hand-to-mouth activities in small children. Methods: Participants were 100 children from the CHARGE (CHildhood Autism Risk from Genetics and the Environment) Study, a case-control epidemiologic investigation of children with autism/autism spectrum disorder, with developmental delay and from the general population. Diagnoses of autism were confirmed by the Autism Diagnostic Observation Schedule and Autism Diagnostic Inventory-Revised, and of developmental delay using the Mullen's Scales of Early Learning and the Vineland Adaptive Behavior Scales. Typically developing controls were those with no evidence of delay, autism, or autism spectrum disorder. Eleven PBDE congeners were measured by gas chromatography/mass spectrometry from serum specimens collected after children were assessed. Logistic regression was used to evaluate the association between plasma PBDEs and autism. Results: Children with autism/autism spectrum disorder and developmental delay were similar to typically developing controls for all PBDE congeners, but levels were high for all three groups. Conclusions: Plasma samples collected post-diagnosis in this study may not represent early life exposures due to changes in diet and introduction of new household products containing PBDEs. Studies with direct measurements of prenatal or infant exposures are needed to assess the possible causal role for these compounds in autism spectrum disorders.

AB - Background. Polybrominated diphenyl ethers (PBDEs) are flame retardants used widely and in increasing amounts in the U.S. over the last few decades. PBDEs and their metabolites cross the placenta and studies in rodents demonstrate neurodevelopmental toxicity from prenatal exposures. PBDE exposures occur both via breastfeeding and hand-to-mouth activities in small children. Methods: Participants were 100 children from the CHARGE (CHildhood Autism Risk from Genetics and the Environment) Study, a case-control epidemiologic investigation of children with autism/autism spectrum disorder, with developmental delay and from the general population. Diagnoses of autism were confirmed by the Autism Diagnostic Observation Schedule and Autism Diagnostic Inventory-Revised, and of developmental delay using the Mullen's Scales of Early Learning and the Vineland Adaptive Behavior Scales. Typically developing controls were those with no evidence of delay, autism, or autism spectrum disorder. Eleven PBDE congeners were measured by gas chromatography/mass spectrometry from serum specimens collected after children were assessed. Logistic regression was used to evaluate the association between plasma PBDEs and autism. Results: Children with autism/autism spectrum disorder and developmental delay were similar to typically developing controls for all PBDE congeners, but levels were high for all three groups. Conclusions: Plasma samples collected post-diagnosis in this study may not represent early life exposures due to changes in diet and introduction of new household products containing PBDEs. Studies with direct measurements of prenatal or infant exposures are needed to assess the possible causal role for these compounds in autism spectrum disorders.

UR - http://www.scopus.com/inward/record.url?scp=78650766930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650766930&partnerID=8YFLogxK

U2 - 10.1186/1476-069X-10-1

DO - 10.1186/1476-069X-10-1

M3 - Article

VL - 10

JO - Environmental Health: A Global Access Science Source

JF - Environmental Health: A Global Access Science Source

SN - 1476-069X

IS - 1

M1 - 1

ER -